Acceleron Pharma
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Acceleron Pharma's past years’ income statements indicate that its last revenue has increased compared to the previous period by 25% to $92,523,000. Profit margin reached -179%. Total operating expenses were $259,829,000.
Profit Margin
| 2011 | 80.91M | 36.26M | 44.82% |
|---|---|---|---|
| 2012 | 15.25M | -32.58M | -213.6% |
| 2013 | 57.23M | -21.89M | -38.26% |
| 2014 | 14.63M | -51.25M | -350.32% |
| 2015 | 18.09M | -63.89M | -353.06% |
| 2016 | 27.77M | -57.01M | -205.3% |
| 2017 | 13.48M | -108.45M | -804.5% |
| 2018 | 13.99M | -118.87M | -849.62% |
| 2019 | 73.99M | -124.85M | -168.74% |
| 2020 | 92.52M | -166.03M | -179.45% |
XLRN Income Statement (2011 – 2020)
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 92.52M | 73.99M | 13.99M | 13.48M | 27.77M | 18.09M | 14.63M | 57.23M | 15.25M | 80.91M |
Cost of revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.5M |
Gross profit | 92.52M | 73.99M | 13.99M | 13.48M | 27.77M | 18.09M | 14.63M | 57.23M | 15.25M | 79.41M |
Operating exp. | ||||||||||
Research and development | 173.91M | 153.95M | 103.90M | 89.72M | 68.58M | 58.40M | 50.89M | 36.05M | 35.31M | 32.71M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 259.82M | 210.43M | 138.40M | 123.46M | 93.87M | 78.97M | 65.09M | 50.27M | 44.14M | 40.85M |
Operating income | -167.30M | -136.44M | -124.41M | -109.98M | -66.10M | -60.87M | -50.46M | 6.95M | -28.88M | 38.55M |
Other income (expenses), net | 1.29M | 11.52M | 5.51M | 1.56M | 9.11M | -3.01M | -795K | -28.85M | -3.69M | 2.29M |
Income before tax | -166.00M | -124.92M | -118.89M | -108.42M | -56.99M | -63.89M | -51.25M | -21.89M | -32.58M | 36.26M |
Income tax expense | 21K | -62K | -27K | 32K | 24K | -3.01M | 127K | -26.75M | 0 | 0 |
Net income | -166.03M | -124.85M | -118.87M | -108.45M | -57.01M | -63.89M | -51.25M | -21.89M | -32.58M | 36.26M |
Earnings per share | ||||||||||
Basic EPS | -2.92 | -2.38 | -2.59 | -2.68 | -1.52 | -1.92 | -1.63 | -1.04 | -1.44 | 0.08 |
Diluted EPS | -2.92 | -2.38 | -2.59 | -2.68 | -1.52 | -1.92 | -1.63 | -1.04 | -1.44 | 0.08 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |